News

Delusional infestation surges during COVID-19 pandemic
- Author:
- Bruce Jancin
Experts weigh in on management of this challenging disorder marked by tenacious false beliefs.
News
Adalimumab enhances primary wound closure after HS surgery
- Author:
- Bruce Jancin
Primary wound closure following surgery for HS is controversial.
News
Hypochlorous acid is a valuable adjunctive treatment in AD
- Author:
- Bruce Jancin
Stabilized topical hypochlorous acid has potent antimicrobial and antipruritic effects.
News
Topical brepocitinib for atopic dermatitis meets endpoints in phase 2b study
- Author:
- Bruce Jancin
First-in-class inhibitor of tyrosine kinase 2 and Janus kinase 1 scores for mild-to-moderate AD.
News
Expert highlights advances in DRESS
- Author:
- Bruce Jancin
Recent data demonstrate that DRESS symptoms often occur within just a week or two of drug exposures.
News
Oral JAK1 inhibitor shows promise for hidradenitis suppurativa
- Author:
- Bruce Jancin
Favorable safety and efficacy shown in phase 2, proof-of-concept studies.
News
Guselkumab maintains psoriasis efficacy long after discontinuation
- Author:
- Bruce Jancin
A potential flexible dosing indication for the IL-23 inhibitor is under study.
News

Dermatologist survey spotlights psoriasis care deficiencies in reproductive-age women
- Author:
- Bruce Jancin
Study suggests dermatologists’ shared decision-making skills need sharpening.
News
Expert panel addresses gaps in acne guidelines
- Author:
- Bruce Jancin
Current acne guidelines fall short regarding long-term maintenance therapy and patient-centered care, experts say.
News
Patients dislike prurigo nodularis treatment options, survey finds
- Author:
- Bruce Jancin
Nearly 30% in European patient survey say no available treatments are effective.
News

Face masks can aggravate rosacea
- Author:
- Bruce Jancin
The mask-aggravated rosacea, or “maskacea,” was mainly localized to the dorsal lower third of the nose as well as the cheeks.
News

Adjuvant nivolumab plus ipilimumab shows strong results in resected stage IV melanoma
- Author:
- Bruce Jancin
Results of German IMMUNED trial turn heads in advanced melanoma field.
News

Deucravacitinib offers biologic-like psoriasis efficacy in oral form
- Author:
- Bruce Jancin
Novel anti-inflammatory mechanism involves selective TYK2 inhibition.
News
Expert offers clinical pearls on leg ulcer therapy
- Author:
- Bruce Jancin
“If no contraindications exist, compression therapy is the best antihypertensive and anti-inflammatory treatment for all leg ulcers, not only...
News

Telltale dermoscopic features of melanomas lacking pigment reviewed
- Author:
- Bruce Jancin
Investigators developed a simple, eight-variable model, which demonstrated a sensitivity of 70% and specificity of 56% for diagnosis of melanoma...